mothertobaby semaglutide pregnancy fact sheet 2024 Infographics Ep. 84 - GLP-1 Medications

Venous thromboembolism, a particularly relevant risk for lupus patients with antiphospholipid antibodies

Depending on glycaemic response and tolerability, the dose may be further increased to 1 mg weekly after at least four weeks, with a maximum licensed dose of 2 mg weekly available for those requiring additional glycaemic control after at least four weeks at the 1 mg dose

Semaglutide is one of several GLP-1 receptor agonists, also known as GLP-1 RAs

Managing Blood Sugar After Stopping Rybelsus After discontinuing Rybelsus, maintaining optimal glycaemic control requires a comprehensive approach combining pharmacological management, lifestyle interventions, and regular monitoring